X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1249) 1249
prasugrel hydrochloride (869) 869
ticlopidine - analogs & derivatives (747) 747
clopidogrel (716) 716
male (664) 664
prasugrel (605) 605
platelet aggregation inhibitors - therapeutic use (597) 597
female (591) 591
middle aged (512) 512
aged (453) 453
cardiac & cardiovascular systems (452) 452
piperazines - therapeutic use (452) 452
thiophenes - therapeutic use (452) 452
percutaneous coronary intervention (451) 451
ticlopidine - therapeutic use (432) 432
treatment outcome (402) 402
acute coronary syndrome - drug therapy (366) 366
platelet aggregation inhibitors - adverse effects (366) 366
adenosine - analogs & derivatives (356) 356
platelet aggregation inhibitors - administration & dosage (347) 347
acute coronary syndromes (310) 310
ticagrelor (298) 298
ticlopidine - administration & dosage (255) 255
aspirin (254) 254
purinergic p2y receptor antagonists - therapeutic use (251) 251
piperazines - administration & dosage (245) 245
thiophenes - administration & dosage (245) 245
piperazines - adverse effects (242) 242
thiophenes - adverse effects (242) 242
ticlopidine - adverse effects (242) 242
adenosine - therapeutic use (237) 237
prasugrel hydrochloride - therapeutic use (236) 236
abridged index medicus (219) 219
hemorrhage - chemically induced (217) 217
acute coronary syndrome (210) 210
platelet aggregation - drug effects (208) 208
platelet aggregation inhibitors - pharmacology (201) 201
pharmacology & pharmacy (200) 200
piperazines - pharmacology (190) 190
blood platelets - drug effects (188) 188
risk factors (188) 188
thiophenes - pharmacology (186) 186
drug therapy, combination (179) 179
time factors (176) 176
prasugrel hydrochloride - administration & dosage (175) 175
antiplatelet therapy (173) 173
coronary heart disease (161) 161
cardiovascular (159) 159
purinergic p2y receptor antagonists - administration & dosage (159) 159
aspirin - therapeutic use (158) 158
hematology (157) 157
prospective studies (157) 157
inhibition (155) 155
peripheral vascular disease (155) 155
adult (151) 151
acute coronary syndrome - therapy (150) 150
myocardial-infarction (149) 149
prasugrel hydrochloride - adverse effects (148) 148
purinergic p2y receptor antagonists - adverse effects (147) 147
intervention (146) 146
blood platelets (145) 145
aggregation (144) 144
stents (144) 144
myocardial infarction - drug therapy (143) 143
cardiac patients (140) 140
platelet function tests (138) 138
heart attacks (130) 130
platelet inhibition (129) 129
care and treatment (125) 125
platelet aggregation inhibitors - pharmacokinetics (124) 124
drug therapy (121) 121
outcomes (119) 119
ticlopidine - pharmacology (119) 119
thrombosis (118) 118
dose-response relationship, drug (116) 116
medicine, general & internal (113) 113
piperazines - pharmacokinetics (109) 109
elevation myocardial-infarction (107) 107
thiophenes - pharmacokinetics (107) 107
platelet reactivity (106) 106
adenosine - administration & dosage (100) 100
mortality (100) 100
randomized controlled trials as topic (99) 99
purinergic p2 receptor antagonists (98) 98
adenosine - adverse effects (97) 97
animals (97) 97
cardiology (97) 97
double-blind (97) 97
purinergic p2y receptor antagonists - pharmacology (97) 97
trial (97) 97
active metabolite (95) 95
aspirin - administration & dosage (95) 95
follow-up studies (95) 95
percutaneous coronary intervention - adverse effects (95) 95
analysis (93) 93
myocardial infarction (92) 92
blood platelets - metabolism (89) 89
double-blind method (88) 88
transluminal angioplasty (88) 88
administration, oral (85) 85
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1289) 1289
German (28) 28
French (9) 9
Italian (7) 7
Spanish (7) 7
Turkish (7) 7
Japanese (6) 6
Russian (5) 5
Polish (3) 3
Chinese (1) 1
Czech (1) 1
Danish (1) 1
Finnish (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bioorganic & medicinal chemistry, ISSN 0968-0896, 2011, Volume 19, Issue 3, pp. 1136 - 1154
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 03/2015, Volume 16, Issue 4, pp. 585 - 596
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 11/2016, Volume 134, Issue 21, pp. 1603 - 1612
Journal Article
Journal of pharmaceutical sciences, ISSN 0022-3549, 09/2019, Volume 108, Issue 9, pp. 2842 - 2857
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 374, Issue 7, pp. 625 - 635
Journal Article
Journal Article
Clinical research in cardiology, ISSN 1861-0692, 2015, Volume 105, Issue 4, pp. 349 - 355
Morphine decreases the concentrations and effects of clopidogrel, which could lead to treatment failure in myocardial infarction.To clarify whether more potent... 
Prasugrel | Medicine & Public Health | Drug interactions | Morphine | Platelet function tests | Cardiology | Vasodilator-stimulated phosphoprotein | MORTALITY | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | PHOSPHORYLATION | REPERFUSION | ACUTE CORONARY SYNDROMES | CLOPIDOGREL | PLATELET INHIBITION | INTERVENTION | ACTIVE METABOLITE | Purinergic P2Y Receptor Antagonists - administration & dosage | Humans | Male | Purinergic P2Y Receptor Antagonists - blood | Drug Monitoring - methods | Healthy Volunteers | Platelet Aggregation Inhibitors - blood | Young Adult | Purinergic P2Y Receptor Antagonists - adverse effects | Tandem Mass Spectrometry | Austria | Analgesics, Opioid - adverse effects | Drug Interactions | Biotransformation | Platelet Aggregation Inhibitors - administration & dosage | Platelet Function Tests | Chromatography, Liquid | Adult | Female | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Prasugrel Hydrochloride - administration & dosage | Prasugrel Hydrochloride - pharmacokinetics | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Risk Assessment | Purinergic P2Y Receptor Antagonists - pharmacokinetics | Prasugrel Hydrochloride - adverse effects | Cross-Over Studies | Analgesics, Opioid - administration & dosage | Morphine - administration & dosage | Morphine - adverse effects | Prasugrel Hydrochloride - blood | Medical colleges | Metabolites | Vasodilators | Clinical trials | Liquid chromatography | Mass spectrometry | Original Paper
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 06/2017, Volume 117, Issue 8, pp. 1582 - 1587
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 06/2019, Volume 321, Issue 24, pp. 2414 - 2427
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 09/2016, Volume 134, Issue 11, pp. 780 - 792
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 381, Issue 16, pp. 1524 - 1534
Journal Article
Journal Article
Vascular pharmacology, ISSN 1537-1891, 2016, Volume 77, pp. 8 - 18
Abstract High on-clopidogrel platelet reactivity (HcPR) during dual-antiplatelet therapy is a marker of vascular risk, in particular stent thrombosis, in... 
Cardiovascular | MAINTENANCE-DOSE CLOPIDOGREL | RESPONSE VARIABILITY | PERCUTANEOUS CORONARY INTERVENTION | OVERCOME CLOPIDOGREL | CARDIOVASCULAR EVENTS | ADJUNCTIVE CILOSTAZOL | NONFATAL MYOCARDIAL-INFARCTION | PHARMACOLOGY & PHARMACY | PROGNOSTIC-SIGNIFICANCE | P2Y RECEPTOR | ANTIPLATELET THERAPY | Adenosine - pharmacokinetics | Age Factors | Ticlopidine - therapeutic use | Humans | Hemorrhage - prevention & control | Drug Interactions | Adenosine - adverse effects | Adenosine - therapeutic use | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Prasugrel Hydrochloride - administration & dosage | Thrombosis - prevention & control | Blood Platelets - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Prasugrel Hydrochloride - pharmacokinetics | Acute Coronary Syndrome - enzymology | Stents | Platelet Aggregation Inhibitors - adverse effects | Cytochrome P-450 CYP2C19 - genetics | Prasugrel Hydrochloride - adverse effects | Adenosine - administration & dosage | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - blood | Polymorphism, Genetic | Prasugrel Hydrochloride - therapeutic use | Acute Coronary Syndrome - drug therapy | Adenosine - analogs & derivatives | Sex Factors | Coronary heart disease | Cardiac patients | Genetic polymorphisms
Journal Article